Navigation Links
Quorum Review IRB and ConsentSolutions Form Strategic Alliance

Seattle, WA (PRWEB) September 05, 2013

Quorum Review, IRB, the industry leader in central IRB services, announces a strategic alliance with Consent Solutions, a developer of internet-based multimedia systems for informed consent in the clinical trials industry. Through the alliance, Quorum Review and Consent Solutions combine and leverage their extensive experience and knowledge to provide an improved informed consent experience.

The alliance demonstrates Quorum Review’s and Consent Solutions’ commitment to enhance the research process, especially as the healthcare industry increasingly adopts electronic data systems. Working together, Quorum Review and Consent Solutions provide an intuitive and effective electronic consent option that meets industry and IRB regulations and standards.

“Quorum Review is excited to work closely with an eConsent provider who understands our industry so well,” says Cami Gearhart, JD, CEO of Quorum Review. “We believe our customers will benefit from this alliance as the healthcare and human research industry move further toward electronic data management.”

"We feel so privileged to be able to work closely with Quorum,” states Susan G. Brink, DrPH, President and CEO of Consent Solutions. “The relationship will allow us to optimize workflows and fine-tune the processes behind electronic consent from the perspective of a leading-edge IRB. Our partnership offers the potential of bringing all of the benefits of eConsent to patients and industry on a much shorter timeline."

About Quorum Review

Quorum Review is an independent institutional review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing IRB review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.

Quorum’s best-in-class IRB services include 14 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the US and Canada, a specialized Phase I team, and unique processes for post-approval and registry studies.

For more information about Quorum Review, visit

About Consent Solutions

Consent Solutions has been spearheading the development and adoption of electronic consent in the clinical space since 2003. The result of extensive and ongoing research with patients, sponsors, regulatory bodies, CROs and IRBs, the Consent Solutions platform, SecureConsent, takes a patient-centered approach that is supported by video and electronic multimedia to facilitate and enhance patient comprehension. Backed by tightly controlled administrative procedures and controls, granular tracking, sophisticated version control and multi-lingual support, the SecureConsent ecosystem tackles many of the problems of paper-based consenting.

For more information about Consent Solutions, visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Quorum Review IRB Board Chair Appointed to SACHRP
2. At RSNA, DR Systems Will Exhibit RIS, Reporting, Peer Review Systems
3. Nucleic Acids Research Journal Publishes Sapphire Energy Peer-Reviewed Research Paper on a Chloroplast Genome From Green Algae
4. Unigenes 2011 Year in Review - Key Elements in Place to Address Debt in 2012
5. FDAs Oncologic Drugs Advisory Committee to Review Resubmitted Pixantrone New Drug Application on February 9, 2012
6. Nonprofit Consortium Publishes Review of Skullcap Adulteration
7. Peer-reviewed Article Reports ProImmune's Immune Formulation 200® Activates the Immune-Support Gene Nrf2.
8. Vitamin D Deficiency Disorders Global Clinical Trials Review, H2, 2012
9. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Second Quarter 2012 Financials
10. Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2012
11. Alzheimers Therapeutics Reviewed by NeuroPerspective
Post Your Comments:
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
(Date:11/24/2015)... ... , ... The United States Golf Association (USGA) today announced Dr. Bruce Clarke, ... annually since 1961, the USGA Green Section Award recognizes an individual’s distinguished service to ... Clarke, of Iselin, N.J., is an extension specialist of turfgrass pathology in the department ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... healthy metabolism. But unless it is bound to proteins, copper is also toxic ... (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic study of ...
(Date:11/24/2015)... , November 24, 2015 ... market research report "Oligonucleotide Synthesis Market by Product & ... Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & ... by MarketsandMarkets, the market is expected to reach USD ... 2015, at a CAGR of 10.1% during the forecast ...
Breaking Biology Technology:
(Date:11/18/2015)... , Nov. 18, 2015  As new scientific ... children, doctors and other healthcare providers face challenges in ... families and patients. In addition, as more children continue ... a patient,s adulthood and old age. John ... The Children,s Hospital of Philadelphia (CHOP) . ...
(Date:11/17/2015)... Paris , qui s,est tenu ... Paris , qui s,est tenu du 17 au ... l,innovation biométrique, a inventé le premier scanner couplé, qui ... même surface de balayage. Jusqu,ici, deux scanners étaient nécessaires, ... digitales. Désormais, un seul scanner est en mesure de ...
(Date:11/16/2015)... Nov 16, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced expansion of its TDDI product ... touch controller and display driver integration (TDDI) solutions ... These new TDDI products add to the previously-announced ... TD4302 (WQHD resolution), and TD4322 (FHD resolution) solutions. ...
Breaking Biology News(10 mins):